miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria
暂无分享,去创建一个
J. Fish | K. Kain | A. Conroy | W. Liles | Junmei Chen | M. Hawkes | José A López | Ying Zheng | J. Harlan | M. Njock | Hani Kim | Jason E. Fish | Ziyue Lu | K. Barker | Henry S. Cheng | Y. Zheng | Ying Zheng | Makon-Sébastien NJOCK | H. Cheng
[1] Ashutosh Kumar Singh,et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.
[2] O. Uthman. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. , 2016, Lancet.
[3] B. Baradaran,et al. BACH1, the master regulator gene: A novel candidate target for cancer therapy. , 2016, Gene.
[4] Chris C. Miller,et al. Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial , 2015, Malaria Journal.
[5] Ryan M. O’Connell,et al. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin , 2015, Nature Communications.
[6] Chen-feng Qi,et al. Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria , 2015, mBio.
[7] M. Cybulsky,et al. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. , 2015, Blood.
[8] Colleen A. Hammond,et al. Brain swelling and death in children with cerebral malaria. , 2015, The New England journal of medicine.
[9] C. Poh,et al. Pathogenic CD8+ T cells in experimental cerebral malaria , 2015, Seminars in Immunopathology.
[10] J. Fish,et al. Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation , 2014, Front. Genet..
[11] Y. Mo,et al. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer , 2014, Molecular Cancer.
[12] C. Poh,et al. Damage to the Blood-Brain Barrier during Experimental Cerebral Malaria Results from Synergistic Effects of CD8+ T Cells with Different Specificities , 2014, Infection and Immunity.
[13] Y. Lévy,et al. Role of miR‐155 in the regulation of lymphocyte immune function and disease , 2014, Immunology.
[14] Michael S. Behnke,et al. miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain. , 2014, Cell reports.
[15] B. Sharrack,et al. MicroRNA‐155 negatively affects blood–brain barrier function during neuroinflammation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] J. Sled,et al. PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria , 2014, PLoS pathogens.
[17] A. Díez,et al. Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria. , 2013, Biochimica et biophysica acta.
[18] K. Mark Ansel,et al. MicroRNA-mediated regulation of T helper cell differentiation and plasticity , 2013, Nature Reviews Immunology.
[19] M. Cybulsky,et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways , 2013, EMBO molecular medicine.
[20] F. Ginhoux,et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection , 2013, Nature Medicine.
[21] H. Moch,et al. Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice , 2013, EMBO molecular medicine.
[22] E. Wherry,et al. MicroRNA-155 controls CD8+ T cell responses by regulating interferon signaling , 2013, Nature Immunology.
[23] W. Liles,et al. Biomarkers of endothelial activation/dysfunction in infectious diseases , 2013, Virulence.
[24] X. Su,et al. Malaria biology and disease pathogenesis: insights for new treatments , 2013, Nature Medicine.
[25] Ying Zheng,et al. In vitro microvessels for the study of angiogenesis and thrombosis , 2012, Proceedings of the National Academy of Sciences.
[26] Scott M. Williams,et al. HMOX1 Gene Promoter Alleles and High HO-1 Levels Are Associated with Severe Malaria in Gambian Children , 2012, PLoS pathogens.
[27] M. Molyneux,et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: A retrospective case–control study* , 2012, Critical care medicine.
[28] A. Tijsen,et al. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.
[29] S. Ylä-Herttuala,et al. Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. , 2011, Free radical biology & medicine.
[30] Chris C. Miller,et al. Inhaled Nitric Oxide Reduces Endothelial Activation and Parasite Accumulation in the Brain, and Enhances Survival in Experimental Cerebral Malaria , 2011, PloS one.
[31] A. Zarbock,et al. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo , 2011, The Journal of experimental medicine.
[32] K. Kain,et al. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics , 2011, Current opinion in hematology.
[33] W. Liles,et al. Endothelial activation, dysfunction and permeability during severe infections , 2011, Current opinion in hematology.
[34] D. Streiner,et al. Combinations of Host Biomarkers Predict Mortality among Ugandan Children with Severe Malaria: A Retrospective Case-Control Study , 2011, PloS one.
[35] M. Molyneux,et al. Endothelium-Based Biomarkers Are Associated with Cerebral Malaria in Malawian Children: A Retrospective Case-Control Study , 2010, PloS one.
[36] Kamolrat Silamut,et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial , 2010, The Lancet.
[37] K. Kain,et al. Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children , 2009, PloS one.
[38] R. Price,et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria , 2008, Proceedings of the National Academy of Sciences.
[39] Samir N. Patel,et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria , 2008, The Journal of experimental medicine.
[40] K. Kain,et al. Pyruvate kinase deficiency and malaria. , 2008, The New England journal of medicine.
[41] M. Mota,et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.
[42] Anton J. Enright,et al. Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.
[43] G. Hutvagner,et al. Principles and effects of microRNA-mediated post-transcriptional gene regulation , 2006, Oncogene.
[44] D. Christiani,et al. Leaking Capillaries and White Lung in Sepsis—Is Angiopoietin 2 the Culprit? Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans. PLoS Medicine 3: e46, 2006 , 2006 .
[45] H. Augustin,et al. Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.
[46] D. Christiani,et al. Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans , 2006, PLoS medicine.
[47] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[48] Arjen Dondorp,et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.
[49] P. Gros,et al. Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.
[50] M. Marron,et al. The Antiinflammatory Endothelial Tyrosine Kinase Tie2 Interacts With a Novel Nuclear Factor-&kgr;B Inhibitor ABIN-2 , 2003, Circulation research.
[51] S. Shibahara,et al. Bach1 Functions as a Hypoxia-inducible Repressor for the Heme Oxygenase-1 Gene in Human Cells* , 2003, The Journal of Biological Chemistry.
[52] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[53] J. York,et al. The Endothelial Receptor Tyrosine Kinase Tie1 Activates Phosphatidylinositol 3-Kinase and Akt To Inhibit Apoptosis , 2002, Molecular and Cellular Biology.
[54] Hyung Jin Kim,et al. Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[55] T. Taylor,et al. Blood-brain barrier function in cerebral malaria in Malawian children. , 2001, The American journal of tropical medicine and hygiene.
[56] Davis,et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. , 1994, The American journal of pathology.
[57] M. Molyneux,et al. Tumor necrosis factor and disease severity in children with falciparum malaria. , 1989, The New England journal of medicine.
[58] K. Kain,et al. S 1 P Is Associated with Protection in Human and Experimental Cerebral Malaria , 2011 .
[59] K. Kain,et al. S1P Is Associated with Protection in Human and Experimental Cerebral Malaria , 2011, Molecular medicine.
[60] J. Gutkind,et al. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. , 2008, Developmental cell.
[61] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .